Today: 9 June 2026
Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus
30 December 2025
1 min read

Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

NEW YORK, December 29, 2025, 10:26 PM ET — Market closed.

  • Lowe’s (LOW) ended down 0.14% at $243.48; it last traded at $243.83 after-hours.
  • U.S. pending home sales jumped to the highest level since February 2023.
  • Traders are lining up Fed minutes and home-price data ahead of Tuesday’s session.

Lowe’s Companies Inc shares finished Monday down 0.14% at $243.48. The stock was last indicated at $243.83 in after-hours trading.

The move kept Lowe’s near a level investors have treated as a referendum on the U.S. housing cycle and interest-rate direction. Home-improvement spending can firm when mortgage rates ease and housing turnover rises, but it tends to stall when homeowners delay big projects.

Housing data delivered a fresh data point late in the session. Contracts to buy existing homes — known as pending home sales, a gauge of signed deals that typically turn into closings a month or two later — rose 3.3% in November, the National Association of Realtors said. “Homebuyer momentum is building,” chief economist Lawrence Yun said. Reuters

The broader tape offered little help. The S&P 500 fell 0.35%, the Nasdaq dropped 0.50% and the Dow lost 0.51% as heavyweight technology shares retreated from last week’s gains, Reuters reported.

Home-improvement retailers moved largely in step with the market’s drift. Home Depot, Lowe’s closest peer, fell 0.67% on the day.

Lowe’s last reshaped investor expectations in November, when it trimmed annual profit and sales forecasts as shoppers deferred bigger renovation work. The retailer pointed to its push to win more professional contractor business as it navigated uneven do-it-yourself demand.

Before Tuesday’s session, traders will focus on the Federal Reserve’s December meeting minutes for signals on how policymakers see the 2026 rate path. Trading has been thin into year-end, which can exaggerate moves, Reuters reported.

Housing-linked releases are also on deck. The S&P CoreLogic Case‑Shiller home price index for October is scheduled for 9 a.m. ET on Tuesday, based on CME Group’s Econoday calendar.

The next company-specific marker is Lowe’s fourth-quarter earnings conference call, listed on its investor calendar as an estimated Feb. 25 event. Investors will watch comparable sales — sales at stores open at least a year — along with updates on Pro demand and margins.

On the chart, traders have treated the $240 area as a key pivot. MarketBeat data put Lowe’s 50-day moving average at $239.87 and its 200-day at $240.62, with a 12-month range of $206.38 to $274.98.

A clearer pickup in housing turnover and affordability would typically support renovation spending, but investors will be watching whether that momentum shows up in traffic and larger project tickets. Until then, Lowe’s trading is likely to stay tethered to rates, housing data and shifting year-end positioning.

Stock Market Today

  • City Chic Collective Limited Nears Breakeven as Analysts Forecast 2027 Profit
    June 9, 2026, 5:30 PM EDT. City Chic Collective Limited (ASX:CCX), a retailer of plus-size women's apparel across Australia, New Zealand, and the U.S., is moving closer to profitability. The company reduced its trailing-twelve-month loss to AU$5.7 million from AU$8.9 million a year earlier. Analysts project a final loss in 2026, with a turnaround to AU$3.6 million profit in 2027, implying a high average growth rate of 106% per year. Notably, City Chic carries no debt, unusual for a growth company still in the investment phase, lowering investment risk. This signals mounting investor confidence as the company approaches breakeven just over a year away. However, meeting aggressive growth targets remains critical to hitting profitability as forecasted.

Latest articles

Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

9 June 2026
Epsium Enterprise soared 72.27% to close at $2.05 on record volume over 65 million shares—more than 200 times its average—before dropping 18.54% after hours to $1.67, as traders piled into the volatile Macau beverage wholesaler despite no major news and fundamentals showing falling revenue and a net loss.
Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look

Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look

9 June 2026
Hims & Hers Health surged 6.6% to $28.98 Tuesday on heavy volume, bucking a tech selloff as investors bet on its ability to profitably scale weight-loss drug sales after a tough quarter marked by missed revenue, a surprise loss, and margin pressure from branded GLP-1s, with new international expansion and Eucalyptus acquisition in focus.
RBC Stock Hits 52-Week High Even as TSX Falls

RBC Stock Hits 52-Week High Even as TSX Falls

9 June 2026
Royal Bank of Canada surged to a new 52-week high at C$277.09 before closing up 1.24% at C$276.01, outpacing the S&P/TSX’s 0.2% drop, after reporting Q2 net income of C$5.5 billion and adjusted EPS of C$3.90, beating estimates. Despite strong results and a 58.61% year-over-year gain, risks remain as the market is not cheap and investors await the Bank of Canada’s rate decision.
BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

9 June 2026
BigBear.ai shares fell 33 cents to $3.98 as investors weighed a Panama cargo-security deployment, annual meeting results, and the company’s ongoing losses; despite a 14% backlog jump and $431.5 million in cash, revenue conversion remains uncertain, and a recent increase in authorized shares raises dilution risks.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Next Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Go toTop